Choolani M - Search Results

1

Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancers.

Das K, Lorena PD, Ng LK, Shen L, Lim D, Siow WY, Narasimhan K, Teh M, Choolani M, Putti TC, Salto-Tellez M. Das K, et al. Among authors: choolani m. Pathology. 2010;42(6):540-6. doi: 10.3109/00313025.2010.508789. Pathology. 2010. PMID: 20854072

2

Application of micro-solid-phase extraction for the determination of persistent organic pollutants in tissue samples.

Basheer C, Narasimhan K, Yin M, Zhao C, Choolani M, Lee HK. Basheer C, et al. Among authors: choolani m. J Chromatogr A. 2008 Apr 4;1186(1-2):358-64. doi: 10.1016/j.chroma.2007.10.015. Epub 2007 Oct 11. J Chromatogr A. 2008. PMID: 17961579

3

Proteomic technologies for prenatal diagnostics: advances and challenges ahead.

Choolani M, Narasimhan K, Kolla V, Hahn S. Choolani M, et al. Expert Rev Proteomics. 2009 Feb;6(1):87-101. doi: 10.1586/14789450.6.1.87. Expert Rev Proteomics. 2009. PMID: 19210129 Review.

4

E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer.

Kothandaraman N, Bajic VB, Brendan PN, Huak CY, Keow PB, Razvi K, Salto-Tellez M, Choolani M. Kothandaraman N, et al. Among authors: choolani m. BMC Cancer. 2010 Feb 24;10:64. doi: 10.1186/1471-2407-10-64. BMC Cancer. 2010. PMID: 20181230 Free PMC article.

5

The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.

Koh SC, Razvi K, Chan YH, Narasimhan K, Ilancheran A, Low JJ, Choolani M; Ovarian Cancer Research Consortium of SE Asia. Koh SC, et al. Among authors: choolani m. Arch Gynecol Obstet. 2011 Jul;284(1):183-90. doi: 10.1007/s00404-010-1605-z. Epub 2010 Aug 1. Arch Gynecol Obstet. 2011. PMID: 20680316

6

Ovarian cancer proteomics: Many technologies one goal.

Narasimhan K, Changqing Z, Choolani M. Narasimhan K, et al. Among authors: choolani m. Proteomics Clin Appl. 2008 Feb;2(2):195-218. doi: 10.1002/prca.200780003. Proteomics Clin Appl. 2008. PMID: 21136825

7

Application of porous membrane protected micro-solid-phase-extraction combined with gas chromatography-mass spectrometry for the determination of estrogens in ovarian cyst fluid samples.

Kanimozhi S, Basheer C, Narasimhan K, Liu L, Koh S, Xue F, Choolani M, Lee HK. Kanimozhi S, et al. Among authors: choolani m. Anal Chim Acta. 2011 Feb 14;687(1):56-60. doi: 10.1016/j.aca.2010.12.007. Epub 2010 Dec 11. Anal Chim Acta. 2011. PMID: 21241846

8

Mining to find the lipid interaction networks involved in Ovarian Cancers.

Kanagasabai R, Narasimhan K, Low HS, Ang WT, Fernandis AZ, Wenk MR, Choolani MA, Baker CJ. Kanagasabai R, et al. Summit Transl Bioinform. 2009 Mar 1;2009:61-5. Summit Transl Bioinform. 2009. PMID: 21347172 Free PMC article.

9

RUNX3 functions as an oncogene in ovarian cancer.

Lee CW, Chuang LS, Kimura S, Lai SK, Ong CW, Yan B, Salto-Tellez M, Choolani M, Ito Y. Lee CW, et al. Among authors: choolani m. Gynecol Oncol. 2011 Aug;122(2):410-7. doi: 10.1016/j.ygyno.2011.04.044. Epub 2011 May 25. Gynecol Oncol. 2011. PMID: 21612813

10

In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer.

Kaur M, MacPherson CR, Schmeier S, Narasimhan K, Choolani M, Bajic VB. Kaur M, et al. Among authors: choolani m. BMC Syst Biol. 2011 Sep 19;5:144. doi: 10.1186/1752-0509-5-144. BMC Syst Biol. 2011. PMID: 21923952 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters